Research Library

Nonresident scholar Kevin Erickson is a co-author of a study that examined trends in employment among patients initiating dialysis and in the six months before end stage renal disease.

In this study, the authors examine the impact of consolidation among U.S. dialysis providers on: 1) the ability of patients to choose among competing dialysis providers and 2) the market concentration of providers in each hospital service area.

The article analyzes the spread of neglected tropical diseases in Somolia due to severe poverty, and civil strife, and discusses the need for reforms to the country’s health systems and infrastructure.

The Medicare program’s transition in 2004 to tiered fee-for-service physician reimbursement for dialysis care had the unintended consequence of reducing use of home dialysis. In this paper, authors evaluate whether payment reform influenced dialysis modality assignment.

Enhancement of American science, technology, engineering, and math education (STEM) at all levels, even early childhood, is a justifiable federal priority.

Every patient with cancer or another life-threatening disease wants the most effective treatment, but drug prices have become staggering. What determines the escalating prices of cancer drugs?

For both generic and patented cancer drugs, the free-market economy has not worked well. Solutions are needed to maintain reasonable drug prices that allow for corporate profits and are affordable to patients and to the U.S. health care system.

The emphasis is on the deterioration of the participation of the political institutions and politicians before the citizenry in Costa Rica, which shows a process of exhaustion, loss of legitimacy of institutions and actors. This process goes back a few decades and shows no sign, in the short term, of the emergence of new structures in the political system. This paper systematizes the morphology of exhaustion and identifies the trends in which the reform can be based. Such reform should be based on constitutional engineering and should support the political reform process from the tendencies of change that are expressed in the political system. Published in Revista Derecho Electoral, December 2013. In Spanish only.

In a genuine effort to protect patients from adverse events, regulatory burdens and research rigidity in clinical trials have increased to a point at which such protection is outweighing the benefits, and actually harming patients who are unable to be involved in clinical trials.

Allowing the producer-dominated market to set drug prices has spiraled the cost of cancer drugs out of control. Drug pricing can be reduced while preserving the profit-making incentive, by linking price to a true measure of quality: preservation and meaningful prolongation of life.